MDT logo

MEDTRONIC PLC

MDTNYSE
πŸ† #133 by market capUS Equity
$87.44β–Ό $2.02 (βˆ’2.31%)
Live
πŸ””
Track MDT
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 2.3%
7dβ–Ό 3.7%
14dβ–Ό 6.8%
30dβ–Ό 4.1%
ytdβ–Ό 9.0%
1yβ–Ό 6.9%
🏦Market Cap
$111.93B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+9.8%
Slowing
πŸ“ŠGross Margin
65.7%
High
πŸ’΅FCF Margin
16.3%
Healthy
βš–οΈP/S Ratio
3.0x
Fair
Otter Score
76
Good

Trading Snapshot

Day Range
$86.72 – $89.14
52-Week Range
$73.31 – $106.33
Volume
$4.41B
Avg Volume
$4.98B
Shares Outstanding
1.28B
Next Earnings
Nov 17, 2026

Fundamentals Snapshot

Annual Revenue
$36.36B
Last Q Revenue
$9.76B
P/E Ratio
21.7
P/S Ratio
3.0x
EPS (TTM)
$4.06
Dividend Yield
3.22%
Dilution (1yr)
βˆ’0.2%

Why Investors Own MDT

  • βœ“High-growth profile β€” revenue up +25.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 78% gross margin and 20% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

MDT logo

MEDTRONIC PLC

MDT
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$36.4Bβ–² +8.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
65.0%β–Ό βˆ’0.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$6.5Bβ–² +8.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$5.4Bβ–² +4.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.29Bβ–Ό βˆ’0.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$26.5Bβ–² +$1.4B YoY
StockOtter Β· stockotter.space

About MEDTRONIC PLC

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
76/100

Analyst Price Target

β“˜
Average Target
$84.76
β–Ό βˆ’3.1% Downside
High Target$100.09
Low Target$70.45
Based on 41 analysts

Latest News & Updates